Compare Lam Research Corporation (LRCX) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lam Research Corporation vs Regeneron Pharmaceuticals Inc — how do they compare? Lam Research Corporation trades at $321.05 (market cap $383.63B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Lam Research Corporation is far larger — about 5.4× Regeneron Pharmaceuticals Inc's market cap, and Regeneron Pharmaceuticals Inc pays the higher dividend (0.56%). Which is the better fit depends on your goals.
| LRCX | REGN | |
|---|---|---|
Market Cap | $383.63B | $70.47B |
Sector | Technology | Health |
52-Week High | $433.33 | $812.27 |
52-Week Low | $94.84 | $545.46 |
Enterprise Value | $382.61B | $64.42B |
Dividend Yield | 0.34% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
